← Back to Dashboard

KSHV

Human gammaherpesvirus 8

4
Approved Drugs
0
Phase 3
3
Phase 2
14
Preclinical
21
Total Compounds

Antiviral Compounds

AmilorideKSHVEpithelial sodium channel inhibitor
Preclinical
—Human ion channel
BrincidofovirKSHVViral DNA polymerase inhibitor
Preclinical
—Viral DNA pol
CamptothecinKSHVTopoisomerase I inhibitor
Preclinical
—Human topoisomerase
ChloroquineKSHVAntimalaria agent; chemo/radio sensitizer
Preclinical
—Human (multiple)
CidofovirKSHVViral DNA polymerase inhibitor
Preclinical
—Viral DNA pol
DocosanolKSHVInhibition of fusion
Phase 2
—Viral glycoprotein
FamciclovirKSHVViral DNA Polymerase Inhibitor
Approved (other)
JapanRussia
Viral DNA pol
FiacitabineKSHVInhibits viral DNA synthesis
Preclinical
—Viral DNA pol
FilociclovirKSHVDual DNA polymerase/kinase inhibitor; Nucleoside analog
Preclinical
—Viral DNA pol
FoscarnetKSHVPyrophosphate analog DNA polymerase inhibitor
Approved (other)
Japan
Viral DNA pol
GlycyrrhizinKSHV—
Preclinical
—Human TNF
Labyrinthopeptin A1KSHVInterference with viral phospholipid membrane
Preclinical
—Viral membrane
Labyrinthopeptin A2KSHVviral membrane lipid phosphatidylethanolamine
Preclinical
—Viral membrane
MetforminKSHVAMPK activator
Preclinical
—Human PTK
MitoxantroneKSHVTopoisomerase II inhibitor
Phase 2
—Human topoisomerase
NelfinavirKSHVHIV protease inhibitor
Approved (other)
Japan
Unknown
NovobiocinKSHVBacterial DNA gyrase inhibitor (targeting GyrB)
Preclinical
—Unknown
SirolimusKSHVIL-2-dependent T-cell proliferation inhibitor
Phase 2
—Human PTK
SorafenibKSHVB-Raf; FGFR-1; VEGFR-2 & -3; PDGFR-beta; KIT; and FLT3 inhibitor
Preclinical
—Human PTK
ValganciclovirKSHVDestabilization of DNA
Approved (other)
Japan
Viral DNA pol
VerdinexorKSHVNuclear export inhibitor
Preclinical
—Human exportin
Showing 1 to 21 of 21 results
Page 1 of 1